Analyst Heather Behanna is focused on the Healthcare sector with 30 price targets and ratings documented since 2014 spanning on 3 stocks. Previously, Heather Behanna worked at WEDBUSH. Analyst's average stock valuation to be materialised ratio is 100% with an average time for price targets to be met of 200.33 days.
Most recent stock forecast was given on SRPT, Sarepta Therapeutics, Inc at 27-Oct-2016.
Heather Behanna best performing recommendations are on SRPT (SAREPTA THERAPEUTICS, INC).
The best stock recommendation documented was for SRPT (SAREPTA THERAPEUTICS, INC) at 5/20/2015. The price target of $25 was fulfilled within 1 day with a profit of $1.24 (4.73%) receiving and performance score of 47.26.
Average potential price target upside
Currently, out of the existing stock ratings of Heather Behanna - 379 which are a Hold (22.79%), 1284 which are a Buy (77.21%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
175
$41.1 (30.69%)
114
7 days ago
9/12 (75%)
$31.76 (43.10%)
464
Buy
160
$26.1 (19.49%)
200
12 days ago
6/15 (40%)
$60.1 (65.22%)
281
Buy
200
$66.1 (49.37%)
226
12 days ago
13/33 (39.39%)
$61.55 (57.74%)
393
Hold
139
$5.1 (3.81%)
144
12 days ago
19/27 (70.37%)
$21.11 (23.06%)
157
Buy
150
$16.1 (12.02%)
180
20 days ago
7/9 (77.78%)
$33.2 (56.64%)
218
